FDA Considers Two New Cholesterol-Lowering Drugs: Advisory Committee Endorses Alirocumab By Sanofi And Regeneron Pharmaceuticals

http://www.ibtimes.com/fda-considers-two-new-cholesterol-lowering-drugs-advisory-committee-endorses-1959557#.VXhQkCPJorM.gmail

Sanofi

Anuncios